Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters

Infection Control and Hospital Epidemiology

Volumn 25, Issue 8, 2004, Pages 650-655

  Rickard, Claire M ^a,b,d   Lipman, Jeff ^a,c   Courtney, Mary ^a,b   Siversen, Rosemary ^a   Daley, Peter ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; LIPID; PROPOFOL; SULFADIAZINE SILVER;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BURN; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; IMMUNE STATUS; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TOTAL PARENTERAL NUTRITION;

BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; COLONY COUNT, MICROBIAL; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 4143100155     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502456     Document Type: Article

References (34)

1. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229-234.
2. Pittet D. Nosocomial bloodstream infections in the critically ill. JAMA 1994;272:1819-1820.
3. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous fluid. Applied Microbiology 1974;28:778-784.
4. Maki DG, Goldmann DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867-887.
5. Centers for Disease Control and Prevention. Nosocomial bacteremia associated with intravenous fluid therapy. MMWR 1971;20:81-82.
6. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products: I. Epidemiologic and clinical features. Am J Med 1976;60:471-485.
7. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979;91:173-178.
8. Buxton AE, Highsmith AK, Garner JS, et al. Contamination of intravascular infusion fluid: effects of changing administration sets. Ann Intern Med 1979;90:764-768.
9. Gorbea HF, Snydman DR, Delaney A, Stockman J, Martin WJ. Intravenous tubing with burettes can be safely changed at 48-hour intervals. JAMA 1984;251:2112-2115.
10. deMoissac D, Jensen L. Changing i.v. administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer? Oncol Nurs Forum 1998;25:907-913.
11. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravascular therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA 1987;258:1777-1781.
12. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987;8:113-116.
13. Robathan G, Woodger S, Merante D. A prospective study evaluating the effects of extending total parenteral nutrition line changes to 72 hours. Journal of Intravenous Nursing 1995;18:84-87.
14. Matlow AG, Kitai I, Kirpalani H, et al. A randomized controlled trial of 72- versus 24-hour intravenous tubing administration set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol 1999;20:487-493.
15. Cohen DM. A replication study: analysis of bacterial contamination of intravenous administration sets in use for 72 hours. Journal of the New York State Nurses Association 1989;20:12.
16. Fox M, Molesky M, Van Aerde JE, Muttitt S. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants. Can J Gastroenterol 1999;13:147-151.
17. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985;9:322-325.
18. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367-370.
19. Raad I, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001;22:136-139.
20. Jakobsen CJ, Grabe N, Nielsen E, et al. Contamination of intravascular infusion systems: the effect of changing administration sets. J Hosp Infect 1986;8:217-223.
21. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51:1-29.
22. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305-1309.
23. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655.
24. Fraenkel DJ, Rickard C, Lipman J. Can we achieve consensus on central venous catheter-related infections? Anaesth Intensive Care 2000;28:475-490.
25. Elliott TSJ, Moss HA, Tebbs SE, et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997;16:210-213.
26. Ducharme FM, Gauthier M, Lacroix J, Lafleur L. Incidence of infection related to arterial catheterization in children: a prospective study. Crit Care Med 1988;16:272-276.
27. Polderman KH, Girbes ARJ. Central venous catheter use: Part 2. infectious complications. Intensive Care Med 2002;28:18-28.
28. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261-267.
29. Cohen J. Statistical Power Analysis for the Behavioural Sciences. Mahwah, NJ: Lawrence Erlbaum Associates; 1988.
30. Eggimann P, Pittett D. Catheter-related infections in the ICU. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer Verlag; 2000:95-110.
31. O'Malley MK, Rhame FS, Cerra FB, McComb RC. Value of routine pressure monitoring system changes after 72 hours of continuous use. Crit Care Med 1994;22:1424-1430.
32. Chen YY, Lin M, Lin MY, Wang FD, Liu JH, Chang MS. The central venous tubing change associated with catheter-related infection. Infect Control Hosp Epidemiol 2000;21:94.
33. Rickard C, Wallis SC, Courtney M, Lipman J, Daley PJP. Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use: an in vitro study. J Adv Nurs 2002;37:330-337.
34. Walters AJ. A Heideggerian hermeneutic study of the practice of critical care nurses. J Adv Nurs 1995;21:492-497.